{
    "nctId": "NCT02969187",
    "officialTitle": "Bupivacaine Liposomal Injection (Exparel) for Postsurgical Analgesia in Patients Undergoing Laparoscopic Bariatric Surgery: A Randomized, Double-Blind, Controlled Trial",
    "inclusionCriteria": "* Fulfills NIH criteria for bariatric surgery\n* Planned operation of laparoscopic Roux-en Y gastric bypass (LRYGB) or laparoscopic sleeve gastrectomy (LSG) as primary bariatric procedure\n* Must have minimum age of 18 Years\n* Must have maximum age of 65 Years",
    "exclusionCriteria": "* BMI \\<35 and \\> 60 kg/m2\n* Inability to walk (bed-bound or wheelchair dependence)\n* Previous major abdominal surgery (possible adhesions and longer operation) defined as:\n\n  * open abdominal surgeries except simple appendectomy and common OB/GYN procedures in the pelvis (hysterectomy, C-section, and oophorectomy, tubal ligation)\n  * laparoscopic bowel or solid organ resection except laparoscopic cholecystectomy\n  * ventral hernia repair with mesh\n* Preoperative chronic opiate use for chronic pain defined as opiate usage at least 60 mg/day of morphine equivalent for \u2265 3 months (as defined by International Association for the Study of Pain22) in the one year period prior to the bariatric surgery\n* The American Society of Anesthesiologists (ASA) score \\> 3\n* History of hypersensitivity or adverse reaction to bupivacaine or narcotics\n* Inability to speak English\n* Concurrent surgical procedure including:\n\n  * ventral hernia repair\n  * Cholecystectomy\n  * hiatal hernia repair with posterior cruroplasty\n  * extensive lysis of adhesions\n  * other procedures that mandate addition of \"trocar(s)\" or \"feeding tube\"\n* Addition of trocar(s) or conversion of surgery to hand-assisted or open"
}